Company intelligence / Profile preview

PanTHERA CryoSolutions

Edmonton, Alberta, Canada

Ownership: Private
Development stage: Other

Overview

PanTHERA has launched its first-generation IRI cryopreservation technology, with next-generation products in development for integration with BioLife Solutions' portfolio. The technology demonstrates improved cell recovery, stability, and logistics efficiency in preclinical and commercial bioproduction applications.

Therapeutic areas: Women's HealthOther
Modalities: Small moleculeBiologicReagent
Industry: Chemicals & Materials

Partnerships

BioLife SolutionsCasdin Capital (via Bioproduction Innovation Accelerator)

Beyond the preview

Go deeper on PanTHERA CryoSolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PanTHERA CryoSolutions.

Explore the full profile